Evidence map›Paper›PMID 33734032›Full record

ArticleEmerging microbes & infections2021

Development of a rapid and sensitive analytical system for

Mai Niikura, Satomi Atobe, Akira Takahashi, Yukiko Kado, Takuya Sugimoto, Hirokazu Tsuji, Kentaro Shimizu, Hiroshi Ogura, Takashi Asahara

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Dysbiosis and Depletion of Fecal Organic Acids Correlate With the Severity of Rejection After Rat Liver Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mai NiikuraYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Satomi AtobeYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Akira TakahashiYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Yukiko KadoYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Takuya SugimotoYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.
Hirokazu TsujiYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2856-6447
Kentaro ShimizuDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Hiroshi OguraDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.ORCID https://orcid.org/0000-0002-5013-2445
Takashi AsaharaYakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsBloodCaco-2 CellsDiagnostic Tests, RoutineDNA, BacterialDrug Resistance, BacterialEarly DiagnosisFecesFemaleHumansInfection ControlIntensive Care UnitsMaleAnti-Bacterial AgentsDNA, BacterialRNA, Ribosomal, 23Santimicrobial resistancebloodfecesICU patientsinfectionmicrobiotaPseudomonas aeruginosaRT-qPCR

Identifiers

PMID33734032
PMCPMC8023615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.